Muscarinic receptor knockout mice confirm involvement of M3 receptor in endothelium-dependent vasodilatation in mouse arteries

Journal of Cardiovascular Pharmacology

Volumn 51, Issue 5, 2008, Pages 505-512

  Bény, Jean Louis ^a   Nguyen, Minh Ngoc ^a   Marino, Mathieu ^a   Matsui, Minoru ^b  

^a UNIVERSITY OF GENEVA   (Switzerland)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Ca2+ signaling; Confocal microscopy; Endothelial cell function; Femoral artery; Mouse; Thoracic aorta

Indexed keywords

ACETYLCHOLINE; MUSCARINIC M1 RECEPTOR; MUSCARINIC M2 RECEPTOR; MUSCARINIC M3 RECEPTOR; VASODILATOR AGENT;

ANIMAL; ARTICLE; CONFOCAL MICROSCOPY; DRUG EFFECT; FEMORAL ARTERY; GENETICS; IN VITRO STUDY; MOUSE; MOUSE MUTANT; PHYSIOLOGY; THORACIC AORTA; VASCULAR ENDOTHELIUM; VASODILATATION;

ACETYLCHOLINE; ANIMALS; AORTA, THORACIC; ENDOTHELIUM, VASCULAR; FEMORAL ARTERY; MICE; MICE, KNOCKOUT; MICROSCOPY, CONFOCAL; RECEPTOR, MUSCARINIC M1; RECEPTOR, MUSCARINIC M2; RECEPTOR, MUSCARINIC M3; VASODILATION; VASODILATOR AGENTS;

EID: 55949094130     PISSN: 01602446     EISSN: 15334023     Source Type: Journal    
DOI: 10.1097/FJC.0b013e31816d5f2f     Document Type: Article

References (56)

1. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 1980;288: 373-376. (Pubitemid 11169009)
2. Palmer RM. Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature. 1987; 327:524-526. (Pubitemid 17085822)
3. Moncada S, Gryglewski R, Bunting S, et al. An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature. 1976;263:663-665.
4. Moncada S, Vane JR. Pharmacology and endogenous roles of prostaglandin endoperoxides, thromboxane A2 and prostacyclin. Pharmacol Rev. 1979;30:293-331.
5. Bény JL, Brunet PC. Neither nitric oxide nor nitroglycerin accounts for all the characteristics of endothelially mediated vasodilatation of pig coronary arteries. Blood Vessels. 1988;25:308-311. (Pubitemid 19010139)
6. Félétou M, Vanhoutte PM. Endothelium-dependent hyperpolarization of canine coronary smooth muscle. Br J Pharmacol. 1988;93:515-524. (Pubitemid 18069063)
7. Taylor SG, Weston AH. Endothelium-derived hyperpolarizing factor: a new endogenous inhibitor from the vascular endothelium. Trends Pharmacol Sci. 1988;9:272-274.
8. Hallam TJ, Pearson JD. Exogenous ATP raises cytoplasmic free calcium in fura-2 loaded piglet aortic endothelial cells. FEBS Lett. 1986;20:95-99. (Pubitemid 17179368)
9. Lückhoff A, Busse R. Increased free calcium in endothelial cells under stimulation with adenine nucleotides. J Cell Physiol. 1986;126:414-420. (Pubitemid 16163726)
10. Johns A, Lategan TW, Lodge NJ, et al. Calcium entry through receptor-operated channels in bovine pulmonary artery endothelial cells. Tissue Cell. 1987;19:733-745. (Pubitemid 18028585)
11. Hallam TJ, Pearson JD, Needham LA. Thrombin-stimulated elevation of human endothelial-cell cytoplasmic free calcium concentration causes prostacyclin production. Biochem J. 1988;251:243-249.
12. Schilling WP, Ritchie AK, Navarro LT, et al. Bradykinin-stimulated calcium influx in cultured bovine aortic endothelial cells. Am J Physiol. 1988;255:H219-227.
13. Tracey WR, Peach MJ. Differential muscarinic receptor mRNA expression by freshly isolated and cultured aortic endothelial cells. Circ Res. 1992;70:234-240.
14. IUPHAR receptor database. Available at: http://www.iuphar-db.org/index. jsp.
15. Brunner F, Kukovetz WR. Radioligand binding to muscarinic receptors of bovine aortic endothelial cells. Br J Pharmacol. 1991;102:373-380.
16. Aronstan RS, Ryan US, Catravas JD. Muscarinic binding sites on bovine pulmonary arterial endothelial cells in culture. Pharmacology. 1992;44: 324-333.
17. Traish AM, Kim N, Carson MP, et al. Characterization of muscarinic acetylcholine receptors in cultured bovine aortic endothelial cells. J Recept Res. 1994;14:153-166. (Pubitemid 24160743)
18. Rubanyi GM, McKinney M, Vanhoutte PM. Biphasic release of endothelium-derived relaxing factor(s) by acetylcholine from perfused canine femoral arteries. Characterization of muscarinic receptors. J Pharmacol Exp Ther. 1987;240:802-808. (Pubitemid 17043578)
19. Garcia-villalon AL, Krause DN, Ehlert FJ, et al. Heterogeneity of muscarinic receptor subtype in cerebral blood vessels. J Pharmacol Exp Ther. 1991;258:304-310.
20. Komori K, Suzuki H. Heterogeneous distribution of muscarinic receptors in the rabbit saphenous artery. Br J Pharmacol. 1987;92:657-664. (Pubitemid 17161068)
21. Orphanos SE, Catravas JD. Muscarinic receptor subtype (M1) identification on rabbit pulmonary vascular endothelium in vivo. Pharmacology. 1989;39:253-254.
22. Horst MA, Sastry BV, Landon EJ. Activities of 5-methylfurfuryltrime- thylammonium iodide and related compounds at vascular endothelial muscarinic receptors of the rat aorta. Arch Int Pharmacodyn Ther. 1987; 288:87-89.
23. Duckles SP, Garcia-villalon AL. Characterization of vascular muscarinic receptors: rabbit ear and bovine coronary artery. J Pharmacol Exp Ther. 1990;253:608-613. (Pubitemid 20181704)
24. Hynes MR, Banner W, Yamamura HI, et al. Characterization of muscarinic receptors of the rabbit ear artery smooth muscle and endothelium. J Pharmacol Exp Ther. 1986;238:100-105. (Pubitemid 16058301)
25. Van Charldorp KJ, van Zwieten PA. Comparison of the muscarinic receptors in the coronary artery, cerebral artery and atrium of the pig. Nauyn-Schmied Arch Pharmacol. 1989;339:403-408. (Pubitemid 19135565)
26. Shimizu T, Rosenblum WI, Nelson GH. M3 and M1 receptors in cerebral arterioles in vivo: evidence for down-regulated or ineffective M1 when endothelium is intact. Am J Physiol. 1993;264:665-669.
27. McCormack DG, Mak JC, Minette P, et al. Muscarinic receptor subtypes mediating vasodilation in the pulmonary artery. Eur J Pharmacol. 1988; 158:293-297. (Pubitemid 19012767)
28. Brunner F, Kühberger E, Groschner K, et al. Characterization of muscarinic receptors mediating endothelium-dependent relaxation of bovine coronary artery. Eur J Pharmacol. 1991;200:25-33.
29. Jaiswal N, Lambrecht G, Mutschler E, et al. Pharmacological Characterization of the vascular muscarinic receptors mediating relaxation and contraction in rabbit aorta. J Pharmacol Exp Ther. 1991;258: 842-850.
30. Dauphin F, Hamel E. Muscarinic receptors subtype mediating vasodila-tation in feline middle cerebral artery exhibits M3 pharmacology. Eur J Pharmacol. 1990;178:203-213. (Pubitemid 20104165)
31. Alonso MJ, Arribas S, Marin J, et al. Presynaptic M2-receptors on noradrenergic nerve endings and endothelium-derived M3 receptors in cat cerebral arteries Brain Res. 1991;567:76-82.
32. Simonsen U, Prieto D, Rivera L, et al. Heterogeneity of muscarinic receptors in lamb isolated coronary resistances arteries. Br J Pharmacol. 1993;109:998-1007. (Pubitemid 23216763)
33. Boulanger CM, Morrison KJ, Vanhoutte PM. Mediation by M3-muscarinic receptors of both endothelium-dependent contraction and relaxation to acetylcholine in the aorta of the spontaneously hypertensive rat. Br J Pharmacol. 1994;112:519-524.
34. Norel X, Walch L, Costantino M, et al. M1 and M3 muscarinic receptors in human coronary arteries. Br J Pharmacol. 1996;119:149-157. (Pubitemid 26294534)
35. Elhusseiny A, Cohen Z, Olivier A, et al. Functional acetylcholine muscarinic receptor subtypes in human brain microcirculation: identification and cellular localization. J Cereb Blood Flow Metab. 1999;19: 794-802. (Pubitemid 30159806)
36. Tayebati SK, Di Tullio MA, Tomassoni D, et al. Localization of the m5 muscarinic cholinergic receptor in rat circle of willis and pial arteries. Neuroscience. 2003;122:205-211 (Pubitemid 37329959)
37. 5 muscarinic acetylcholine receptor function by the use of gene targeting technology. Life Sciences. 2003;74:345-353. (Pubitemid 37357065)
38. -/- mice. Eur J Pharmacol. 2004;493:127-132. (Pubitemid 38746941)
39. Colden-Stanfield M, Schilling WP, Ritchie AK, et al. Bradykinin-induced increases in cytosolic calcium and ionic currents in cultured bovine aortic endothelial cells. Circ Res. 1987;61:632-640. (Pubitemid 17157303)
40. Hallam TJ, Jacob R, Merritt JE. Evidence that agonists stimulate bivalent-cation influx into human endothelial cells. Biochem J. 1988;255: 179-184.
41. Lückhoff A, Zeh R, Busse R. Desensitization of the bradykinin-induced rise in intracellular free calcium in cultured endothelial cells. Europ J Physiol. (Pflügers Arch) 1988;412:654-658.
42. Marie I, Bény JL. Calcium imaging of murine thoracic aorta endothelium by confocal microscopy reveals inhomogeneous distribution of endothe-lial cells responding to vasodilator agent. J Vasc Res. 2002;39:260-267. (Pubitemid 34827793)
43. Bkaily G, Pothier P, D'Orléans-Juste P, et al. The use of confocal microscopy in the investigation of cell structure and function in the heart, vascular endothelium and smooth muscle cells. Mol Cell Biochem. 1997; 172:171-194. (Pubitemid 27374586)
44. Budel S, Schuster A, Stergiopoulos N, et al. Role of smooth muscle cells on endothelial cell cytosolic free calcium in porcine coronary artery. Am J Physiol. 2001;281:H1156-H1162.
45. Dora KA, Doyle MP, Duling BR. Elevation of intracellular calcium in smooth muscle causes endothelial cell generation of NO in arterioles. Proc Natl Acad Sci U S A. 1997;94:6529-6534. (Pubitemid 27270719)
46. 2+-measurements with visible wavelength indicators in isolated cardiac myocytes. Cell Calcium. 1993; 14:359-372. (Pubitemid 23162142)
47. Niggli E, Lederer WJ. Real-time confocal microscopy and calcium measurements in heart muscle cells: towards the development of a fluorescence microscope with high temporal and spatial resolution. Cell Calcium. 1990;11:121-130. (Pubitemid 20095537)
48. Schuster A, Oishi H, Bény JL, et al. Simultaneous arterial calcium dynamics and diameter measurements: application to myoendothelial communication. Am J Physiol. 2001;257:H778-H784.
49. Usachev YM, Marchenko SM, Sage SO. Cytosolic calcium concentration in resting and stimulated endothelium of excised intact rat aorta. J Physiol. 1995;489:309-317. (Pubitemid 26009414)
50. 2+ signaling between smooth muscle and endothelium of resistance vessels. Circ Res. 2000;87:1048-1054.
51. i in rat afferent arteriole during constriction measured with confocal fluorescence microscopy. Am J Physiol. 1996; 271:F1004-F1011.
52. Ohno-Shosaku T, Matsui M, Fukudome Y, et al. Postsynaptic M1 and M3 receptors are responsible for the muscarinic enhancement of retrograde endocannabinoid signalling in the hippocampus. Eur J Neurosci. 2003;18: 109-16. (Pubitemid 36920851)
53. Matsui M, Motomura D, Fujikawa T, et al. Mice lacking M2 and M3 muscarinic acetylcholine receptors are devoid of cholinergic smooth muscle contractions but still viable. J Neurosci. 2002;22:10627-10632. (Pubitemid 36005136)
54. Matsui M, Motomura D, Karasawa H, et al. Multiple functional defects in peripheral autonomic organs in mice lacking muscarinic acetylcholine receptor gene for the M3 subtype. Proc Natl Acad Sci USA. 2000;97: 9579-9584. (Pubitemid 30650818)
55. Chataigneau T, Félétou M, Huang PL, et al. Acetylcholine-induced relaxation in blood vessels from endothelial nitric oxide synthase knockout mice. Br J Pharmacol. 1999;126:219-226. (Pubitemid 29041761)
56. Bény JL. Cheracterization of purine receptors in mouse aorta. J Cardiovasc Pharmacol. 2004;44:171-177.